Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human XCL1/Lymphotactin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 695LT025/CF
This item is not returnable.
View return policy
Description
Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human XCR1. The ED50 for this effect is 0.0800-0.500 μg/mL.Specifications
Lyophilized from a 0.2 μm filtered solution in PBS. | |
10.4 kDa | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
6375 | |
XCL1/Lymphotactin | |
E. coli-derived human XCL1/Lymphotactin protein Val22-Gly114,with an N-terminal Met | |
Unconjugated | |
97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction